Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
14.12
+0.17 (1.22%)
At close: Apr 30, 2025

Chongqing Pharscin Pharmaceutical Company Description

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China.

The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections.

It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases.

The company was founded in 1996 and is headquartered in Chongqing, China.

Chongqing Pharscin Pharmaceutical Co., Ltd.
Country China
Founded 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,384
CEO Xiaoying Liu

Contact Details

Address:
No. 89, Middle Section of Huangshan Avenue
Chongqing, 401120
China
Phone 86 23 6762 2999
Website pharscin.com

Stock Details

Ticker Symbol 002907
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100003308
SIC Code 2834

Key Executives

Name Position
Xiaoying Liu Chief Executive Officer, GM and Director
Xiaoyan Peng Accounting Supervisor and Chief Financial Officer
Ying Wang Head of Phramaceutical Sales, Deputy GM and Director
Xue Dan You Deputy GM, Secretary of the Board and Non-Independent Director
Yong Lu Hang Chief Operating Officer and Deputy GM
Lie Chun Chen Chief Technology Officer
Xu Jun Securities Affairs Representative